Novo A/S »

Miragen Therapeutics shares owned by Novo A/S

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Novo A/S

Quarter filed Position value Share count Share price at filing
2024-09-30 $54M 2.4M 22.75
2024-06-30 $26M 2.0M 13.01
2024-03-31 $19M 1.1M 17.51

More positions owned by Novo A/S

Vanguard Index Fds Total Stk Mkt (VTI)
Tempus Ai Cl A (TEM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Edgewise Therapeutics (EWTX)
Corcept Therapeutics Incorporated (CORT)
Asml Holding N V N Y Registry Shs (ASML)
salesforce (CRM)
Vaxcyte (PCVX)
Mirum Pharmaceuticals (MIRM)
Miragen Therapeutics (VRDN)
Alibaba Group Hldg Sponsored Ads (BABA)
Insmed Com Par $.01 (INSM)
Crinetics Pharmaceuticals In (CRNX)
Cable One (CABO)
Arrivent Biopharma (AVBP)

View all positions for Novo A/S

Top funds holding Miragen Therapeutics

BlackRock
BlackRock
Deep Track Capital
VR Adviser
Fairmount Funds Management
Vanguard Group
Paradigm Biocapital Advisors
Perceptive Advisors
State Street Corporation
Commodore Capital
Novo A/S
Tang Capital Management
Alliancebernstein
Maverick Capital
Driehaus Capital Management

View all funds holding Miragen Therapeutics